Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 969824, 9 pages
http://dx.doi.org/10.1155/2013/969824
Research Article

Electroacupuncture and Rosiglitazone Combined Therapy as a Means of Treating Insulin Resistance and Type 2 Diabetes Mellitus: A Randomized Controlled Trial

1Department of Internal Medicine and Emergency Medicine, Division of Endocrinology and Metabolism, Tungs’ Taichung Metro Harbor Hospital, Taichung County, Taiwan
2Department of Traditional Chinese Medicine, China Medical University Hospital, Taichung City, Taiwan
3Department of Acupuncture, China Medical University Hospital, Taichung City, Taiwan
4Department of Orthopedics, Taichung Veterans General Hospital, Taichung City, Taiwan
5College of Life Science, National Tsing Hua University, Hsinchu City, Taiwan
6Department of Traditional Chinese Medicine, En Chu Kong Hospital, Taipei, Taiwan
7Division of Traditional Chinese Medicine, Chia-Yi Christian Hospital, Chiayi City, Taiwan
8Department of Medicinal Botanicals and Health Applications, Da-Yeh University, Changhua County 51591, Taiwan
9School of Chinese Medicine for Post-Baccalaureate, I-SHOU University, Kaohsiung County, Taiwan
10School of Chinese Medicine, China Medical University, Taichung City, Taiwan

Received 21 February 2013; Revised 19 April 2013; Accepted 28 April 2013

Academic Editor: Gerhard Litscher

Copyright © 2013 Rong-Tsung Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, pp. 539–553, 1998. View at Google Scholar
  2. P. Zimmet, K. G. M. M. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. K. H. Yoon, J. H. Lee, J. W. Kim et al., “Epidemic obesity and type 2 diabetes in Asia,” Lancet, vol. 368, no. 9548, pp. 1681–1688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Goodyear and B. B. Kahn, “Exercise, glucose transport, and insulin sensitivity,” Annual Review of Medicine, vol. 49, pp. 235–261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. J. Hunter and W. T. Garvey, “Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system,” American Journal of Medicine, vol. 105, no. 4, pp. 331–345, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. C. G. Ostenson, “The pathophysiology of type 2 diabetes mellitus: an overview,” Acta Physiologica Scandinavica, vol. 171, pp. 241–247, 2001. View at Publisher · View at Google Scholar
  7. J. M. Olefsky and A. R. Saltiel, “PPARγ and the treatment of insulin resistance,” Trends in Endocrinology and Metabolism, vol. 11, no. 9, pp. 362–368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Senna-Fernandes, D. França, S. F. R. Moreno et al., “The effect of "Zusanli" (ST. 36) acupuncture on the bio-availability of sodium pertechnetate in Wister rats,” Acupuncture and Electro-Therapeutics Research, vol. 31, no. 1-2, pp. 33–44, 2006. View at Google Scholar · View at Scopus
  10. J. G. Lin, W. C. Chen, C. L. Hsieh et al., “Multiple sources of endogenous opioid peptide involved in the hypoglycemic response to 15 Hz electroacupuncture at the Zhongwan acupoint in rats,” Neuroscience Letters, vol. 366, no. 1, pp. 39–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Nolan, “Failure of islet β-cell compensation for insulin resistance causes type 2 diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis?” Journal of Gastroenterology and Hepatology, vol. 25, no. 10, pp. 1594–1597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Chang, K. J. Lin, R. T. Lin, P. H. Hung, J. G. Lin, and J. T. Cheng, “Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats,” Life Sciences, vol. 79, no. 10, pp. 967–971, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. C. Lee, T. M. Li, C. Y. Tzeng et al., “Electroacupuncture-induced cholinergic nerve activation enhances the hypoglycemic effect of exogenous insulin in a rat model of streptozotocin-induced diabetes,” Experimental Diabetes Research, vol. 2011, Article ID 947138, 7 pages, 2011. View at Publisher · View at Google Scholar
  14. H. C. Pai, C. Y. Tzeng, Y. C. Lee et al., “Increase in Plasma Glucose Lowering Action of Rosiglitazone by Electroacupuncture at Bilateral Zusanli Acupoints (ST.36) in Rats,” JAMS Journal of Acupuncture and Meridian Studies, vol. 2, no. 2, pp. 147–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  16. American Diabetes Association, “Screening for type 2 diabetes,” Diabetes Care, vol. 21, pp. S20–S22, 1998. View at Google Scholar
  17. S. L. Chang, J. G. Lin, C. L. Hsieh, and J. T. Cheng, “Comparision of hypoglycemic effect in different acupoints response to 2 Hz electroacupuncture,” The Journal of Chinese Medicine, vol. 13, pp. 111–117, 2002. View at Google Scholar
  18. T. Porstmann and S. T. Kiessig, “Enzyme immunoassay techniques. An overview,” Journal of Immunological Methods, vol. 150, no. 1-2, pp. 5–21, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Chen, D. Gong, and Y. Zhai, “Clinical and experimental studies in treating diabetes mellitus by acupuncture,” Journal of Traditional Chinese Medicine, vol. 14, no. 3, pp. 163–166, 1994. View at Google Scholar · View at Scopus
  20. R. X. Wei, J. Xiang, and Q. Dong, “Considerations on syndrome differentiation and acupuncture treatment of diabetic peripheral neuropathy,” Journal of Acupuncture and Tuina Science, vol. 5, no. 5, pp. 260–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Wang, “The present situation of TCM treatment for diabetes and its researches,” Journal of Traditional Chinese Medicine, vol. 23, no. 1, pp. 67–73, 2003. View at Google Scholar · View at Scopus
  22. S. L. Chang, C. C. Tsai, J. G. Lin, C. L. Hsieh, R. T. Lin, and J. T. Cheng, “Involvement of serotonin in the hypoglycemic response to 2 Hz electroacupuncture of zusanli acupoint (ST36) in rats,” Neuroscience Letters, vol. 379, no. 1, pp. 69–73, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Ohkubo, H. Kishikawa, E. Araki et al., “Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study,” Diabetes Research and Clinical Practice, vol. 28, no. 2, pp. 103–117, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: aonsensus statement from the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetologia, vol. 52, no. 1, pp. 17–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Kahn, “Consensus development conference on insulin resistance: 5-6 november 1997,” Diabetes Care, vol. 21, no. 2, pp. 310–314, 1998. View at Google Scholar · View at Scopus
  26. C. N. O. Jones, D. Pei, P. Staris, K. S. Polonsky, Y. D. I. Chen, and G. M. Reaven, “Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, pp. 1834–1838, 1997. View at Google Scholar · View at Scopus
  27. R. T. Lin, C. Y. Tzeng, Y. C. Lee et al., “Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats,” BMC Complementary and Alternative Medicine, vol. 9, article 26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Olefsky, R. R. Revers, M. Prince et al., “Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus,” Advances in Experimental Medicine and Biology, vol. 189, pp. 176–205, 1985. View at Google Scholar · View at Scopus
  29. S. Del Prato, F. Leonetti, D. C. Simonson, P. Sheehan, M. Matsuda, and R. A. DeFronzo, “Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man,” Diabetologia, vol. 37, no. 10, pp. 1025–1035, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Alemzadeh, G. Langley, L. Upchurch, P. Smith, and A. E. Slonim, “Beneficial effect of diazoxide in obese hyperinsulinemic adults,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 6, pp. 1911–1915, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. L. C. Groop, R. C. Bonadonna, S. DelPrato et al., “Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance,” Journal of Clinical Investigation, vol. 84, no. 1, pp. 205–213, 1989. View at Google Scholar · View at Scopus
  32. J. Denis McGarry, “Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes,” Diabetes, vol. 51, no. 1, pp. 7–18, 2002. View at Google Scholar · View at Scopus
  33. R. T. Lin, C. Y. Chen, C. Y. Tzeng et al., “Electroacupuncture improves glucose tolerance through cholinergic nerve and nitric oxide synthase effects in rats,” Neuroscience Letters, vol. 494, no. 2, pp. 114–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Chang, Y. C. Lee, T. M. Li et al., “Electroacupuncture at the Zusanli (ST-36) acupoint induces a hypoglycemic effect by stimulating the cholinergic nerve in a rat model of streptozotocine-induced insulin-dependent diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 650263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Charles, E. Eschwège, N. Thibult et al., “The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris prospective study,” Diabetologia, vol. 40, no. 9, pp. 1101–1106, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. A. H. Mokdad, E. S. Ford, B. A. Bowman et al., “Diabetes trends in the U.S.: 1990–1998,” Diabetes Care, vol. 23, no. 9, pp. 1278–1283, 2000. View at Google Scholar · View at Scopus
  37. G. M. Reaven, C. Hollenbeck, C. Y. Jeng, M. S. Wu, and Y. D. I. Chen, “Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM,” Diabetes, vol. 37, no. 8, pp. 1020–1024, 1988. View at Google Scholar · View at Scopus
  38. G. Boden and G. I. Shulman, “Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction,” European Journal of Clinical Investigation, vol. 32, supplement 3, pp. 14–23, 2002. View at Publisher · View at Google Scholar · View at Scopus